Literature DB >> 30567735

Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1.

Julie Sanchez1,2, Zil E Huma1,2, J Robert Lane2,3, Xuyu Liu4, Jessica L Bridgford1,2, Richard J Payne4, Meritxell Canals5,3, Martin J Stone6.   

Abstract

Interactions between secreted immune proteins called chemokines and their cognate G protein-coupled receptors regulate the trafficking of leukocytes in inflammatory responses. The two-site, two-step model describes these interactions. It involves initial binding of the chemokine N-loop/β3 region to the receptor's N-terminal region and subsequent insertion of the chemokine N-terminal region into the transmembrane helical bundle of the receptor concurrent with receptor activation. Here, we test aspects of this model with C-C motif chemokine receptor 1 (CCR1) and several chemokine ligands. First, we compared the chemokine-binding affinities of CCR1 with those of peptides corresponding to the CCR1 N-terminal region. Relatively low affinities of the peptides and poor correlations between CCR1 and peptide affinities indicated that other regions of the receptor may contribute to binding affinity. Second, we evaluated the contributions of the two CCR1-interacting regions of the cognate chemokine ligand CCL7 (formerly monocyte chemoattractant protein-3 (MCP-3)) using chimeras between CCL7 and the non-cognate ligand CCL2 (formerly MCP-1). The results revealed that the chemokine N-terminal region contributes significantly to binding affinity but that differences in binding affinity do not completely account for differences in receptor activation. On the basis of these observations, we propose an elaboration of the two-site, two-step model-the "three-step" model-in which initial interactions of the first site result in low-affinity, nonspecific binding; rate-limiting engagement of the second site enables high-affinity, specific binding; and subsequent conformational rearrangement gives rise to receptor activation.
© 2019 Sanchez et al.

Entities:  

Keywords:  CCR1; G protein-coupled receptor (GPCR); binding; chemokine; chemokine receptor; cytokine; innate immunity; molecular pharmacology; receptor activation; receptor structure-function; signaling; three-step model

Mesh:

Substances:

Year:  2018        PMID: 30567735      PMCID: PMC6416418          DOI: 10.1074/jbc.RA118.006535

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection.

Authors:  R Horuk; C Clayberger; A M Krensky; Z Wang; H J Grone; C Weber; K S Weber; P J Nelson; K May; M Rosser; L Dunning; M Liang; B Buckman; A Ghannam; H P Ng; I Islam; J G Bauman; G P Wei; S Monahan; W Xu; R M Snider; M M Morrissey; J Hesselgesser; H D Perez
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

2.  Biased signaling at chemokine receptors.

Authors:  Jenny Corbisier; Céline Galès; Alexandre Huszagh; Marc Parmentier; Jean-Yves Springael
Journal:  J Biol Chem       Date:  2015-01-22       Impact factor: 5.157

Review 3.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

4.  Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.

Authors:  Zil E Huma; Julie Sanchez; Herman D Lim; Jessica L Bridgford; Cheng Huang; Bradyn J Parker; Jiann G Pazhamalil; Benjamin T Porebski; Kevin D G Pfleger; J Robert Lane; Meritxell Canals; Martin J Stone
Journal:  Sci Signal       Date:  2017-05-23       Impact factor: 8.192

5.  Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.

Authors:  John Z Zhu; Christopher J Millard; Justin P Ludeman; Levi S Simpson; Daniel J Clayton; Richard J Payne; Theodore S Widlanski; Martin J Stone
Journal:  Biochemistry       Date:  2011-02-04       Impact factor: 3.162

Review 6.  Therapeutic potential of CCR1 antagonists for multiple myeloma.

Authors:  Angela R Karash; Annette Gilchrist
Journal:  Future Med Chem       Date:  2011-11       Impact factor: 3.808

7.  Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.

Authors:  Georgina Xanthou; Timothy J Williams; James E Pease
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

8.  Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B.

Authors:  C D Paavola; S Hemmerich; D Grunberger; I Polsky; A Bloom; R Freedman; M Mulkins; S Bhakta; D McCarley; L Wiesent; B Wong; K Jarnagin; T M Handel
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

9.  Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.

Authors:  Justin Liu; Samuel Louie; Willy Hsu; Kristine M Yu; Hugh B Nicholas; Grace L Rosenquist
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-24       Impact factor: 6.914

10.  Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor.

Authors:  J L Gao; D B Kuhns; H L Tiffany; D McDermott; X Li; U Francke; P M Murphy
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses.

Authors:  Ram Prasad Bhusal; Simon R Foster; Martin J Stone
Journal:  Protein Sci       Date:  2019-10-24       Impact factor: 6.725

Review 2.  Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors.

Authors:  Holger Bronger; Viktor Magdolen; Peter Goettig; Tobias Dreyer
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

3.  Submolecular probing of the complement C5a receptor-ligand binding reveals a cooperative two-site binding mechanism.

Authors:  Andra C Dumitru; R N V Krishna Deepak; Heng Liu; Melanie Koehler; Cheng Zhang; Hao Fan; David Alsteens
Journal:  Commun Biol       Date:  2020-12-18

4.  Behavior of Chemokine Receptor 6 (CXCR6) in Complex with CXCL16 Soluble form Chemokine by Molecular Dynamic Simulations: General Protein‒Ligand Interaction Model and 3D-QSAR Studies of Synthetic Antagonists.

Authors:  Giovanny Aguilera-Durán; Antonio Romo-Mancillas
Journal:  Life (Basel)       Date:  2021-04-15

5.  Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.

Authors:  Emma Probst Brandum; Astrid Sissel Jørgensen; Marina Barrio Calvo; Katja Spiess; Francis C Peterson; Zhang Yang; Brian F Volkman; Christopher T Veldkamp; Mette Marie Rosenkilde; Christoffer Knak Goth; Gertrud Malene Hjortø
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

6.  Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.

Authors:  Giovanny Aguilera-Durán; Antonio Romo-Mancillas
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

7.  Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1.

Authors:  Zhehua Shao; Qingya Shen; Bingpeng Yao; Chunyou Mao; Li-Nan Chen; Huibing Zhang; Dan-Dan Shen; Chao Zhang; Weijie Li; Xufei Du; Fei Li; Honglei Ma; Zhi-Hua Chen; H Eric Xu; Songmin Ying; Yan Zhang; Huahao Shen
Journal:  Nat Chem Biol       Date:  2021-12-23       Impact factor: 16.174

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.